← Eichor
Study identifier: NCT05987774 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Improving Social Communication in Individuals With ASD Using AI

Condition: Autism Spectrum Disorder  ·  Sponsor: Stanford University

PhaseNA
Planned participants540
Who can joinAll sexes, 11 Years to 35 Years
Healthy volunteersNo

About this study

The purpose of this study is to identify whether researched and commonly used face-to-face interventions can be effectively implemented through artificial intelligence (AI) using an application on the phone or computer. The investigators plan to recruit verbal individuals diagnosed with autism spectrum disorder who demonstrate challenges with socialization. Modules focusing on various difficulties experienced by autistic individuals will provide practice and feedback using voice recognition and feedback. If effective, this intervention can be scaled up to provide cost-effective accessible assistance to individuals, particularly those who do not have access to care or prefer to secure services in the comfort of their own homes.

This description comes directly from the study's public registry record.

Talk to the study team

Lynn K Koegel, PhD  ·  8056899493  ·  lynnk@stanford.edu

Monica Lam, PhD  ·  6502240595  ·  lam@stanford.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Stanford University School of MedicineStanford, California, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05987774